An abnormal herpes test result means the test detected either the herpes simplex virus itself or antibodies your immune system made in response to it, but the practical meaning of that result varies enormously depending on which test was performed and what the numbers look like. A swab-based test taken from an active sore is fairly reliable, while a blood test can produce false positives at a surprisingly high rate, especially in people who have never had symptoms. Understanding the difference between test types and knowing what your specific index value means can save you from weeks of unnecessary panic or, conversely, from dismissing a result that actually matters.
Swab Tests and Blood Tests Tell You Different Things
Herpes testing falls into two broad categories. The first is direct detection: a clinician swabs a sore, blister, or suspicious area and sends it to a lab to look for the virus itself. The second is serology, a blood draw that checks whether your body has produced antibodies against herpes simplex virus type 1 (HSV-1) or type 2 (HSV-2). These two approaches answer fundamentally different questions. A swab tells you whether active virus is present right now, in that specific spot. A blood test tells you whether your immune system has encountered the virus at some point in the past.
Among swab-based methods, PCR (which amplifies viral DNA so tiny amounts become detectable) has largely replaced the older technique of growing the virus in a cell culture. PCR picks up more true infections than culture does. In one comparison involving skin lesions, virus isolation detected HSV-2 in about a quarter of samples, while PCR caught it in more than a third.1PubMed. Detection of herpes simplex virus type 1, herpes simplex virus type 2 and varicella-zoster virus in skin lesions. Comparison of real-time PCR, nested PCR and virus isolation A study of neonatal swab specimens found culture had only 50 percent sensitivity compared with 100 percent for PCR, and PCR produced no false positives.2PubMed Central. Comparison of Herpes Simplex Virus PCR with Culture for Virus Detection in Multisource Surface Swab Specimens from Neonates If your abnormal result came from a PCR swab of an actual lesion, it is one of the most trustworthy results you can get.
Blood tests are a different story. They are the tests most commonly ordered when someone has no visible sores but wants to “check their status,” and they are the tests most likely to produce confusing or misleading abnormal results.
The Low-Positive Zone and Why It Matters
Most commercial HSV-2 blood tests report an index value rather than a simple positive or negative. The standard cutoff is 1.1: anything at or above that number is flagged as positive. But researchers and clinicians have known for years that values between roughly 1.1 and 3.5 sit in a gray zone where false positives are common. The CDC itself has recommended confirmatory testing for results in this low-positive range, and the data backs up that caution.
In one analysis of 262 specimens that screened positive for HSV-2 antibodies, 124 turned out to be false positives when put through a confirmatory inhibition assay. About 20 percent of those false positives had index values above 3.5 on the initial screening test, meaning even some higher-value results were wrong.3PubMed. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results Among specimens that truly were positive, at least three-quarters had indices above 3.5. So a high index value makes a true positive much more likely, but a low-positive value is genuinely ambiguous and should never be taken at face value.
If your blood test came back with an index value between 1.1 and 3.5, you should treat it as a “maybe” rather than a definitive diagnosis. Ask your clinician about confirmatory testing before making any decisions about disclosure, treatment, or emotional response.
How HSV-1 Antibodies Can Confuse HSV-2 Results
One source of false or indeterminate HSV-2 results is something most people never hear about: cross-reactivity with HSV-1. The two viruses are close relatives, and antibodies against one can sometimes interfere with tests designed to detect the other. This is not just a theoretical concern. In a large dataset of over 21,000 specimens that screened positive for HSV-2 antibodies, researchers found that samples yielding indeterminate results on the confirmatory inhibition assay were disproportionately likely to also be positive for HSV-1 antibodies, with 83 percent of those indeterminate samples carrying HSV-1 antibodies compared with 60 percent among samples that were confirmed negative.4PubMed Central. Relationship Between HSV-1 Serostatus and HSV-2 IgG Confirmation Results Using an Inhibition Assay
The researchers suggested that very high levels of HSV-1 antibodies may create a complex that interferes with how the confirmatory test detects HSV-2 antibodies binding to their target.4PubMed Central. Relationship Between HSV-1 Serostatus and HSV-2 IgG Confirmation Results Using an Inhibition Assay In practical terms, this means that if you already carry HSV-1 (which most adults do, often from childhood cold sores), your HSV-2 blood test has a higher chance of producing a murky result. This is one more reason low-positive HSV-2 index values deserve scrutiny rather than blind acceptance.
A separate study found even more striking numbers in a clinical population: among patients with PCR-confirmed HSV-2 genital infections, only about 38 percent tested positive for HSV-2 IgG antibodies, while many were positive only for HSV-1 IgG.5PubMed Central. Comparison of the Accuracy of HSV1 and HSV2 Antibody Tests with PCR in the Diagnosis of Recurrent Genital Herpes That study highlights just how unreliable antibody testing alone can be for pinning down which virus type is actually causing genital symptoms.
Testing Too Early After Exposure
Another reason a blood test might give you misleading information is timing. Antibodies do not appear in your blood the moment you are exposed to herpes. There is a window period during which you could be genuinely infected but still test negative, and the length of that window depends on the test being used.
In a study tracking seroconversion after a first symptomatic herpes episode, the median time from symptom onset to a positive result on the HerpeSelect ELISA was about three weeks for both HSV-1 and HSV-2. But the gold-standard Western blot took longer, with a median of 33 days for HSV-1 and 40 to 47 days for HSV-2.6PubMed. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2 Some individuals took considerably longer. If you were tested within the first few weeks after a possible exposure and received a negative result, that does not rule out a recent infection. Retesting after two to three months gives the immune system enough time to produce detectable antibodies.
Conversely, if you were tested very early and got a borderline-positive result, it could represent genuine early seroconversion or it could be noise. The timing conversation is essential context for interpreting any herpes blood test, and it is a conversation many clinicians do not volunteer unless you ask.
An Abnormal Test Without Symptoms Is More Common Than You Think
One of the most disorienting aspects of getting a positive herpes result is having no memory of an outbreak. You may assume the test must be wrong. But the reality is that most people with HSV-2 either never develop recognizable symptoms or have symptoms so mild they get attributed to something else. Research suggests that more than 80 percent of HSV-2 infections are asymptomatic, unrecognized, or misdiagnosed because the classic genital ulcers are absent.7The Journal for Nurse Practitioners. Screening for Asymptomatic Genital Herpes: Is Serologic Testing Worth It?
Even without symptoms, the virus can still shed from the skin. A study that tracked daily genital swabs found that people with asymptomatic HSV-2 infection shed virus on close to 9 percent of days sampled. People with symptomatic HSV-2 shed on about 13 percent of days, but the amount of virus present during each shedding episode was nearly identical in both groups.8PubMed Central. Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons with HSV-2 Infection So an asymptomatic positive result does not mean the virus is dormant or harmless. It means transmission to a partner is possible even when you feel completely fine.
HSV-1 and HSV-2 Behave Differently Below the Belt
If your test distinguished between HSV-1 and HSV-2, the type matters for understanding what to expect. Both can infect the genital area, but HSV-2 is much more likely to recur. In a study that followed patients after their first symptomatic genital herpes episode, 89 percent of those with HSV-2 had at least one recurrence within a year, and 20 percent had more than ten recurrences.9Annals of Internal Medicine. Recurrence rates in genital herpes after symptomatic first-episode infection Genital HSV-1, by contrast, recurs much less frequently, with many people experiencing only one or two episodes before the virus settles into long-term latency.
This distinction matters for treatment decisions, partner counseling, and your own mental health. A genital HSV-1 diagnosis is not benign, but it typically means fewer outbreaks and lower rates of asymptomatic shedding than genital HSV-2. If your test came back positive but did not specify the type, it is worth asking your provider whether the test distinguished between HSV-1 and HSV-2, because many standard panels do not.
Why Your Doctor Probably Didn’t Screen You in the First Place
You may wonder why herpes testing is not part of routine STI panels. The U.S. Preventive Services Task Force has explicitly recommended against routine serologic screening for genital herpes in asymptomatic adolescents and adults, including pregnant individuals. Their reasoning centers on the high rate of false-positive results, especially among people with a low likelihood of infection, and the fact that confirmatory testing is rarely performed in practice.10PubMed Central. Reaffirmed USPSTF Recommendation Against Serologic Screening for Genital Herpes: Empowering Clinicians and Reducing Potential Harm
The logic is straightforward: if you screen a million people who have no symptoms, you will generate a large number of false positives that cause real psychological harm without catching enough true cases to justify the cost. That does not mean testing is never appropriate. It is useful when you have symptoms, when a partner has a known herpes diagnosis, when you are pregnant and your partner’s status is unclear, or when you specifically request it after a potential exposure. The recommendation against screening is not a recommendation against testing when there is a clinical reason to test.
Pregnancy and Neonatal Risk
An abnormal herpes test takes on a different urgency during pregnancy. Neonatal herpes, while rare, can be serious, and the timing of the mother’s infection is what drives the risk. The greatest danger to a newborn comes when the mother acquires herpes for the first time in the second half of pregnancy, because her body has not yet built up the antibodies that would otherwise offer the baby some passive protection during delivery.11PubMed Central. Herpes simplex virus infection in pregnancy
A study from Stockholm found that newly acquired genital herpes in pregnancy was associated with a substantially elevated risk of disseminated herpes in the newborn, though the confidence interval was wide enough that the precise magnitude remains uncertain.12PubMed. Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes If you are pregnant and get an abnormal herpes test, your obstetrician will want to determine whether this represents a longstanding infection or a new one, because the management strategy is entirely different. A woman who has carried HSV-2 for years and has established antibodies faces a much lower risk of transmitting during delivery than a woman who just acquired the virus at 30 weeks.
HSV-2 and HIV Susceptibility
One less commonly discussed implication of a positive HSV-2 result is that it roughly doubles or triples the risk of acquiring HIV if you are exposed to it. A systematic review and meta-analysis found that among general populations, prevalent HSV-2 infection was associated with an almost threefold increase in HIV acquisition risk, and incident (newly acquired) HSV-2 infection carried an even higher risk, with nearly a fivefold increase.13The Lancet Infectious Diseases. Association between herpes simplex virus type 2 and risk of HIV acquisition: a systematic review and meta-analysis The mechanism involves HSV-2 drawing immune cells that HIV targets to the genital area and creating microscopic breaks in the mucosal barrier.
This does not mean an HSV-2 diagnosis should cause alarm about HIV. It means that if you test positive for HSV-2 and are sexually active with partners of unknown HIV status, there is an added practical reason to use barrier protection and, in some cases, to discuss pre-exposure prophylaxis for HIV with your provider.
Antiviral Treatment and Lowering Transmission Risk
If your abnormal test turns out to be a true positive, daily antiviral therapy is one of the most effective tools for managing the infection and reducing the risk of passing it to a partner. In a large randomized trial, daily valacyclovir cut the rate of HSV-2 transmission to susceptible partners by about half compared with placebo. The drug also reduced the frequency of detectable viral shedding dramatically: from about 11 percent of days on placebo down to roughly 3 percent of days on the antiviral.14PubMed. Once-daily valacyclovir to reduce the risk of transmission of genital herpes
Daily suppressive therapy is not mandatory. Some people with infrequent outbreaks prefer episodic treatment, taking the medication only when they feel an outbreak starting. Others who have frequent recurrences or who are in a relationship with an HSV-negative partner choose daily suppression for both symptom control and partner protection.15PubMed Central. Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy? The choice is personal and depends on outbreak frequency, relationship context, and your own comfort level. The key point is that a confirmed positive test does not leave you without options.
The Emotional Fallout of a Positive Result
The medical reality of herpes and the emotional reality of a herpes diagnosis are wildly out of proportion to each other. For many people, the psychological impact of a positive test far outweighs the physical burden of the infection itself. Research into the psychosocial effects of receiving a positive HSV-2 serology result found a range of persistent emotional responses: fear of disclosing to future partners, feeling sexually undesirable, a sense of being “damaged goods,” avoidance of sex out of anxiety about transmission, and strained relationships.16PubMed Central. Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment
Some of that anguish is amplified by the fact that many people receive a positive blood test result without adequate counseling about what the numbers mean, whether confirmatory testing is needed, or how common the infection actually is. When someone Googles “abnormal herpes test” at midnight, they are often not looking for virology. They are looking for someone to explain whether their life just changed. The honest answer is that for most people with HSV-2, the infection is a manageable skin condition with effective treatment, and the social stigma surrounding it is vastly disproportionate to its medical significance.
Newer Diagnostic Approaches on the Horizon
The limitations of current blood tests have pushed researchers toward better diagnostic tools. Microfluidics-based point-of-care tests, which aim to deliver results at the bedside or in a clinic visit rather than requiring a reference lab, are in development.17PubMed Central. Diagnosis of Herpes Simplex Virus: Laboratory and Point-of-Care Techniques The hope is that these newer platforms will narrow the gap between the excellent accuracy of PCR-based swab testing and the convenience of a quick screening test. For now, though, the most reliable way to confirm a herpes diagnosis when symptoms are present remains a PCR swab of the lesion, and the most reliable way to resolve an ambiguous blood result is a confirmatory test like the Western blot or an inhibition assay.
If you have already received an abnormal result and are trying to figure out what to do next, the most important step is not to accept or reject the result in isolation. Ask what test was used, what the index value was, whether confirmatory testing is warranted, and whether a type-specific result is available. The answers to those questions will tell you far more than the word “abnormal” ever could.